Exicure, Inc. Files Definitive Proxy Statement

Ticker: XCUR · Form: DEF 14A · Filed: Dec 2, 2024 · CIK: 1698530

Exicure, Inc. DEF 14A Filing Summary
FieldDetail
CompanyExicure, Inc. (XCUR)
Form TypeDEF 14A
Filed DateDec 2, 2024
Risk Levellow
Pages16
Reading Time19 min
Key Dollar Amounts$0.0001, $8,700,000, $3.00, $8.7 million, $1.3 million
Sentimentneutral

Sentiment: neutral

Topics: proxy-statement, regulatory-filing, corporate-governance

Related Tickers: EXCR

TL;DR

Exicure (EXCR) filed its proxy statement, standard procedure for shareholder meetings.

AI Summary

Exicure, Inc. filed a definitive proxy statement (DEF 14A) on December 2, 2024, related to its annual meeting. The filing indicates no fee was required for this submission. Exicure, Inc. was formerly known as Max-1 Acquisition Corp until a name change on February 21, 2017.

Why It Matters

This filing is a standard procedural document for public companies, informing shareholders about upcoming meetings and voting matters, which is crucial for corporate governance.

Risk Assessment

Risk Level: low — This is a routine regulatory filing and does not contain new material financial or operational information.

Key Players & Entities

  • EXICURE, INC. (company) — Registrant
  • Max-1 Acquisition Corp (company) — Former Company Name
  • 20170221 (date) — Date of Name Change
  • 20241202 (date) — Filing Date

FAQ

What is the purpose of a DEF 14A filing?

A DEF 14A filing, or definitive proxy statement, is used by companies to solicit proxies from shareholders for an upcoming meeting, providing detailed information about the matters to be voted upon.

When was Exicure, Inc. formerly known by another name?

Exicure, Inc. was formerly known as Max-1 Acquisition Corp until February 21, 2017.

What is the filing date of this document?

This definitive proxy statement was filed on December 2, 2024.

Was there a filing fee associated with this DEF 14A?

According to the filing, no fee was required for this submission.

What is the Standard Industrial Classification (SIC) code for Exicure, Inc.?

The SIC code for Exicure, Inc. is 2834, which corresponds to Pharmaceutical Preparations.

Filing Stats: 4,828 words · 19 min read · ~16 pages · Grade level 12.3 · Accepted 2024-12-02 12:00:52

Key Financial Figures

  • $0.0001 — Shares") of our common stock, par value $0.0001 (the "Common Stock"), for $8,700,000 (o
  • $8,700,000 — value $0.0001 (the "Common Stock"), for $8,700,000 (or $3.00 per share). Among other condi
  • $3.00 — the "Common Stock"), for $8,700,000 (or $3.00 per share). Among other conditions, the
  • $8.7 million — the Purchase Agreement of approximately $8.7 million. In connection with the Purchase Agree
  • $1.3 million — per share, for total proceeds to us of $1.3 million. This purchase was made pursuant to a s

Filing Documents

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT 12 HOUSEHOLDING OF PROXY MATERIALS 13 STOCKHOLDER PROPOSALS FOR THE 2025 ANNUAL MEETING 14 OTHER MATTERS 15 ANNEX A – PURCHASE AGREEMENT 16 ANNEX B – REGISTRATION RIGHT AGREEMENT 46 EXICURE, INC. 2430 N. Halsted Street Chicago, Illinois 60614 PROXY STATEMENT FOR THE SPECIAL MEETING OF STOCKHOLDERS TO BE HELD ON DECEMBER 17, 2024 GENERAL INFORMATION This proxy statement, the annexes hereto and related materials (collectively, this "Proxy Statement") is being furnished in connection with the solicitation of proxies by the Board of Directors (the "Board") of Exicure, Inc. ("Exicure," the "Company," "we," "our" or "us"), for use at our special meeting of stockholders (including any adjournments or postponements thereof, the "Special Meeting") to be held virtually on December 17, 2024 at 900 a.m. Central Time. On November 13, 2024, the Company entered into a common stock purchase agreement (the "Purchase Agreement") with HiTron Systems Inc. ("HiTron"), pursuant to which the Company agreed, subject to the satisfaction of certain conditions, to issue and sell to HiTron 2,900,000 newly issued shares (the "Shares") of our common stock, par value $0.0001 (the "Common Stock"), for $8,700,000 (or $3.00 per share). Among other conditions, the closing of the Purchase Agreement is subject to approval of our stockholders. At the Special Meeting, you will be asked to consider and vote on a proposal to approve the issuance of the Shares pursuant to the Purchase Agreement, which would result in a "change of control" of the Company under the applicable rules of The Nasdaq Stock Market LLC ("Nasdaq"). If the Purchase Agreement is approved by our stockholders, following the Closing, HiTron will become our majority shareholder, owning approximately 61% of our Common Stock. We urge you to read carefully this entire Proxy Statement because it contains important information that you should consider in d

View Full Filing

View this DEF 14A filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.